Abstract:Background The balance between protein synthesis and degradation (proteostasis) is a determining factor for muscle size and function. Signaling via the mammalian target of rapamycin complex 1 (mTORC1) regulates proteostasis in skeletal muscle by affecting protein synthesis and autophagosomal protein degradation. Indeed, genetic inactivation of mTORC1 in developing and growing muscle causes atrophy resulting in a lethal myopathy. However, systemic dampening of mTORC1 signaling by its allosteric inhibitor rapamycin is beneficial at the organismal level and increases lifespan. Whether the beneficial effect of rapamycin comes at the expense of muscle mass and function is yet to be established. Methods We conditionally ablated the gene coding for the mTORC1-essential component raptor in muscle fibers of adult mice (iRAmKO). We performed detailed phenotypic and biochemical analyses of iRAmKO mice and compared them with RAmKO mice, which lack raptor in developing muscle fibers. We also used polysome profiling and proteomics to assess protein translation and associated signaling in skeletal muscle of iRAmKO mice. Results Analysis at different time points reveal that, as in RAmKO mice, the proportion of oxidative fibers decreases, but slow-type fibers increase in iRAmKO mice. Nevertheless, no significant decrease in body and muscle mass, or muscle fiber area was detected up to 5 months post-raptor depletion. Similarly, ex vivo muscle force was not significantly reduced in iRAmKO mice. Despite stable muscle size and function, inducible raptor depletion significantly reduced the expression of key components of the translation machinery and overall translation rates. Conclusions Raptor depletion and hence complete inhibition of mTORC1 signaling in fully-grown muscle leads to metabolic and morphological changes without inducing muscle atrophy even after 5 months. Together, our data indicate that maintenance of muscle size does not require mTORC1 signaling, suggesting that rapamycin treatment is unlikely to negatively affect muscle mass and function.

A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan

The mTOR pathway is necessary for survival of mice with short telomeres

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing

Hypothalamic Mtorc2 is Essential for Metabolic Health and Longevity

Cap-independent translation: A shared mechanism for lifespan extension by rapamycin, acarbose, and 17α-estradiol

Cap-independent mRNA translation is upregulated in long-lived endocrine mutant mice

Characterization of Effects of mTOR Inhibitors on Aging in Caenorhabditis elegans

Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice

Ribosomal S6 kinase 1 regulates inflammaging via the senescence secretome

mTOR-dependent translation amplifies microglia priming in aging mice

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

Inhibition of S6K lowers age-related inflammation and increases lifespan through the endolysosomal system

The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging

mTORC1 signaling is not essential for the maintenance of muscle mass and function in adult sedentary mice

Anabolic Function Downstream of TOR Controls Trade-offs Between Longevity and Reproduction at the Level of Specific Tissues in C. elegans

Aging--lost in Translation?

Nucleolar stress caused by arginine-rich peptides triggers a ribosomopathy and accelerates aging in mice

ATF-4 and hydrogen sulfide signalling mediate longevity in response to inhibition of translation or mTORC1

Rapalink-1 reveals novel mTOR-dependent genes and an agmatinergic axis-based metabolic feedback regulating mTOR activity and lifespan

Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models.